Craig A. Collard, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 27,150 shares at $13.54 ($368K) on 2022-05-16, disclosed to the SEC on 2022-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| Filing → |
| OPNT | BUY | 2022-05-16 | $39K | — | Filing → |
| SRRA | BUY | 2021-11-24 | $622K | — | Filing → |
| OPNT | BUY | 2021-09-15 | $45K | — | Filing → |